Table 2. Association between cytoplasmic FOXO1 and pFOXO1 expression and clinico-pathological parameters.

Variables	N	High Cystoplasmic FOXO1 expression		P-value	High Cytoplasmic pFOXO1 expression		P-value
		Number (%)	Odds ratio (95%CI)		Number (%)	Odds ratio (95%CI)
Age (Years)
≤50	102	40 (39.2%)	1	0.001	39 (38.2%)	1	0.066
>50	79	50 (63.3%)	2.67 (1.46–4.90)		41 (51.9%)	1.74 (0.96–3.16)
Gender
Male	124	57 (46.0%)	1	0.136	55 (44.4%)	1	0.980
Female	57	33 (57.9%)	1.62 (0.86–3.05)		25 (43.9%)	0.98 (0.52–1.84)
Seisure
No	149	77 (51.7%)	1	0.257	67 (45.0%)	1	0.654
Yes	32	13 (40.6%)	0.64 (0.30–1.39)		13 (40.6%)	0.84 (0.39–1.82)
IICP
No	112	50 (44.6%)	1	0.082	52 (46.4%)	1	0.442
Yes	69	40 (58.0%)	1.71 (0.93–3.14)		28 40.6%)	0.79 (0.43–1.45)
MTD
<5 cm	80	42 (52.5%)	1	0.506	34 (42.5%)	1	0.682
≥5 cm	101	48 (47.5%)	0.82 (0.46–1.48)		46 (45.5%)	1.13 (0.63–2.04)
WHO grade
II	61	21 (34.4%)	1	0.001	21 (34.4%)	1	0.102
III	27	10 (37.0%)	1.12 (0.44–2.88)		11 (40.7%)	1.31 (0.52–3.33)
IV	93	59 (63.4%)	3.30 (1.68–6.50)		48 (44.2%)	2.03 (1.04–3.96)

Abbreviations: IICP, increased intracranial pressure; MTD, mean tumor diameter.